Astal Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 157295,
    "name": "Astal Lab",
    "stock_name": "Astal Lab",
    "full_name": "Astal Laboratories Ltd",
    "name_url": "stocks-analysis/astal-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "83.95",
    "chg": 2.57,
    "chgp": "3.16%",
    "dir": 1,
    "prev_price": "81.38",
    "mcapval": "354.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 512600,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE307N01014",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "17.29 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/astal-lab-157295-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Astal Laboratories Ltd Valuation Shifts Amid Market Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-valuation-shifts-amid-market-rally-3980554",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstalLaboratori_valuationdot_3980554.png",
        "date": "2026-05-08 08:00:04",
        "description": "Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a significant shift in its valuation parameters, moving from an expensive to a very expensive rating. This change comes amid a strong day gain of 17.61% and a mixed performance relative to the Sensex over various time frames, prompting a detailed analysis of its price attractiveness and comparative metrics."
      },
      {
        "title": "Astal Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-is-rated-sell-3975849",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstalLaboratori_mojoScore_3975849.png",
        "date": "2026-05-05 10:10:02",
        "description": "Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Astal Laboratories Ltd Falls to 52-Week Low of Rs 61 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-stock-hits-52-week-low-at-rs61-3964550",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_priceRelatedfactors_3964550.png",
        "date": "2026-04-27 13:35:05",
        "description": "For the third consecutive session, Astal Laboratories Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 61 on 27 Apr 2026. This marks a significant 40.8% drop from its 52-week high of Rs 103.2, underscoring persistent selling pressure despite some positive financial indicators."
      },
      {
        "title": "Astal Laboratories Ltd Falls to 52-Week Low of Rs 62.49 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-stock-hits-52-week-low-at-rs6249-3960908",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_priceRelatedfactors_3960908.png",
        "date": "2026-04-24 12:35:05",
        "description": "For the second consecutive session, Astal Laboratories Ltd has closed lower, slipping to a fresh 52-week low of Rs 62.49 on 24 Apr 2026, extending its year-long decline despite some encouraging financial metrics."
      },
      {
        "title": "Astal Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-is-rated-sell-3960722",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_mojoScore_3960722.png",
        "date": "2026-04-24 10:10:03",
        "description": "Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Astal Laboratories Ltd Falls to 52-Week Low of Rs 63 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-falls-to-52-week-low-of-rs63-amid-market-divergence-3956017",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_priceRelatedfactors_3956017.png",
        "date": "2026-04-21 11:40:10",
        "description": ""
      },
      {
        "title": "Astal Laboratories Ltd: Valuation Shift Signals Price Attractiveness Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-valuation-shift-signals-price-attractiveness-amid-market-challenges-3946372",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_valuationdot_3946372.png",
        "date": "2026-04-15 08:00:14",
        "description": "Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has seen its valuation parameters shift notably, moving from a very expensive to an expensive rating. This change reflects a subtle but significant deterioration in price attractiveness, driven by a combination of elevated price-to-earnings and price-to-book ratios relative to historical and peer benchmarks. Investors face a challenging landscape as the stock underperforms broader indices and peers, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Astal Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-is-rated-sell-3944678",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_mojoScore_3944678.png",
        "date": "2026-04-13 10:10:14",
        "description": "Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with an up-to-date perspective on its performance and outlook."
      },
      {
        "title": "Astal Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-is-rated-sell-3930253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_mojoScore_3930253.png",
        "date": "2026-04-02 10:10:16",
        "description": "Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 15,
    "sid": "157295",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/astal-laboratories-157295"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Jun-2026",
      "details": "Newspaper publication.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Jun-2026",
      "details": "Submission of newspaper publication for financial results for the quarter and year ended March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 (LODR) 2015- Authorization Of Kmps Under Regulation 30(5)",
      "datetime": "01-Jun-2026",
      "details": "Intimation of authorization of KMPs under regulation 30 (5) of SEBI (LODR) Regulations 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Astal Laboratories Ltd Valuation Shifts Amid Market Rally

2026-05-08 08:00:04

Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a significant shift in its valuation parameters, moving from an expensive to a very expensive rating. This change comes amid a strong day gain of 17.61% and a mixed performance relative to the Sensex over various time frames, prompting a detailed analysis of its price attractiveness and comparative metrics.

Astal Laboratories Ltd is Rated Sell

2026-05-05 10:10:02

Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Astal Laboratories Ltd Falls to 52-Week Low of Rs 61 as Sell-Off Deepens

2026-04-27 13:35:05

For the third consecutive session, Astal Laboratories Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 61 on 27 Apr 2026. This marks a significant 40.8% drop from its 52-week high of Rs 103.2, underscoring persistent selling pressure despite some positive financial indicators.

Astal Laboratories Ltd Falls to 52-Week Low of Rs 62.49 as Sell-Off Deepens

2026-04-24 12:35:05

For the second consecutive session, Astal Laboratories Ltd has closed lower, slipping to a fresh 52-week low of Rs 62.49 on 24 Apr 2026, extending its year-long decline despite some encouraging financial metrics.

Astal Laboratories Ltd is Rated Sell

2026-04-24 10:10:03

Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Astal Laboratories Ltd Falls to 52-Week Low of Rs 63 as Sell-Off Deepens

2026-04-21 11:40:10

Astal Laboratories Ltd: Valuation Shift Signals Price Attractiveness Amid Market Challenges

2026-04-15 08:00:14

Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has seen its valuation parameters shift notably, moving from a very expensive to an expensive rating. This change reflects a subtle but significant deterioration in price attractiveness, driven by a combination of elevated price-to-earnings and price-to-book ratios relative to historical and peer benchmarks. Investors face a challenging landscape as the stock underperforms broader indices and peers, prompting a reassessment of its investment appeal.

Astal Laboratories Ltd is Rated Sell

2026-04-13 10:10:14

Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with an up-to-date perspective on its performance and outlook.

Astal Laboratories Ltd is Rated Sell

2026-04-02 10:10:16

Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

View All News